Companies Dominating the Overactive Bladder Treatment Landscape
- Astellas Pharma, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer, Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Endo International Plc.
- Johnson & Johnson Private Limited
- India Medtronic Private Limited
- Boston Scientific Corporation
- Cognetix Medical, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Overactive Bladder Treatment Market in 2025 is estimated at USD 5.46 billion.
The global market size was valued at over USD 5.17 billion in 2024 and is expected to expand at a CAGR of around 6.9%, surpassing USD 12.31 billion revenue by 2037.
North America is forecast to secure USD 4.92 billion by 2037, driven by growing investment in healthcare.
The major players in the market include Astellas Pharma, Inc., Pfizer, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Endo International Plc., Johnson & Johnson Private Limited, India Medtronic Private Limited, Boston Scientific Corporation, Cognetix Medical, Inc.
